Profil
Palle Christophersen is the founder of Cephagenix ApS, founded in 2020, and Saniona AB, founded in 2011, where the title held is Executive Vice President-Research.
The current job is Chief Scientific Officer at Saniona A. Former job includes Vice President & Director-Vitro Pharmacology at NTG Nordic Transport Group A from 1991 to 2012.
Education includes a doctorate from the University of Copenhagen.
Aktive Positionen von Palle Christophersen
| Unternehmen | Position | Beginn |
|---|---|---|
| SANA AB | Gründer | 01.01.2011 |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Palle Christophersen
| Unternehmen | Position | Ende |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | 01.01.2012 |
Cephagenix ApS
Cephagenix ApS BiotechnologyHealth Technology Engages in identifying and developing new, effective migraine therapies | Gründer | - |
Ausbildung von Palle Christophersen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
NTG Nordic Transport Group A/S
NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saniona AB
Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Commercial Services |
Cephagenix ApS
Cephagenix ApS BiotechnologyHealth Technology Engages in identifying and developing new, effective migraine therapies | Health Technology |
















